retatrutide type 2 diabetes trial results 2024 🚨Breaking: Retatrutide's first Phase 3 T2D data just dropped. ▸ A1C: −2.0% at 40 weeks ▸ Weight: −36.6 lbs (−16.8%) at 12 mg ▸ No weight loss plateau — curve still descending Retatrutide produces up to 30.3%

Choose Compact, Protein-Dense Formats Some foods deliver more protein in smaller portions

Please reach out to the authors, your Foley relationship partner, or to our Health Care Practice Group and Health Care & Life Sciences Sector with any questions.

Comprehensive Health Evaluation Advanced Lab Panels: These panels provide a detailed overview of your overall health, helping identify factors that could influence weight management, metabolism, and hormone balance

We make no representations or warranties of any kind, express or implied, about the completeness, accuracy, reliability, suitability, or availability of the information contained herein

This project is financially supported by the Swedish Foundation for Strategic Research

GLP-1s offer proven benefits, but they do not replace blood pressure control or statin therapy